Mengis Capital Management, Inc. Merck & Co., Inc. Transaction History

Mengis Capital Management, Inc.

$487 Million
Q2 2024

A detailed history of Mengis Capital Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 111,745 shares of MRK stock, worth $11.4 Million. This represents 2.84% of its overall portfolio holdings.

Number of Shares

111,745

Previous 126,604 11.74%

Holding current value

$11.4 Million

Previous $15.7 Million 11.73%

% of portfolio

2.84%

Previous 2.46%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $1.84 Million - $1.98 Million	-14,859 Reduced 11.74%	111,745 $13.8 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $402,341 - $468,818	3,553 Added 2.89%	126,604 $16.7 Million
Q4 2023 Feb 01, 2024	SELL	$100.18 - $109.02 $74,834 - $81,437	-747 Reduced 0.6%	123,051 $13.4 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $59,402 - $65,968	-577 Reduced 0.46%	123,798 $12.7 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $533,275 - $581,245	-4,910 Reduced 3.8%	124,375 $14.4 Million
Q1 2023 May 05, 2023	SELL	$102.94 - $114.86 $1.2 Million - $1.34 Million	-11,648 Reduced 8.26%	129,285 $13.8 Million
Q4 2022 Feb 01, 2023	SELL	$87.44 - $112.11 $400,387 - $513,351	-4,579 Reduced 3.15%	140,933 $15.6 Million
Q3 2022 Nov 04, 2022	SELL	$84.53 - $94.96 $562,462 - $631,863	-6,654 Reduced 4.37%	145,512 $12.5 Million
Q2 2022 Jul 19, 2022	SELL	$83.49 - $94.64 $111,876 - $126,817	-1,340 Reduced 0.87%	152,166 $13.9 Million
Q1 2022 May 02, 2022	BUY	$73.51 - $82.4 $11,761 - $13,184	160 Added 0.1%	153,506 $12.6 Million
Q4 2021 Feb 04, 2022	BUY	$72.28 - $90.54 $506,827 - $634,866	7,012 Added 4.79%	153,346 $11.8 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $115,333 - $126,837	1,609 Added 1.11%	146,334 $11 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $1.23 Million - $1.36 Million	17,456 Added 13.72%	144,725 $11.3 Million
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $629,655 - $741,669	9,144 Added 7.74%	127,269 $9.81 Million
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $1.04 Million - $1.15 Million	14,488 Added 13.98%	118,125 $9.66 Million
Q3 2020 Oct 29, 2020	BUY	$73.18 - $82.95 $553,972 - $627,931	7,570 Added 7.88%	103,637 $8.6 Million
Q2 2020 Jul 22, 2020	BUY	$70.42 - $80.13 $481,672 - $548,089	6,840 Added 7.67%	96,067 $7.43 Million
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $902,183 - $1.25 Million	14,239 Added 18.99%	89,227 $6.87 Million
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $671,454 - $757,658	8,655 Added 13.05%	74,988 $6.82 Million
Q3 2019 Nov 05, 2019	BUY	$76.08 - $82.93 $5.05 Million - $5.5 Million	66,333 New	66,333 $5.58 Million

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.

Account

Mengis Capital Management, Inc. Merck & Co., Inc. Transaction History